hydrochlorothiazide has been researched along with Flushing in 2 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Flushing: A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of pulmonary edema induced by a common diuretic, hydrochlorothiazide." | 5.32 | [Acute non-cardiogenic pulmonary edema secondary to hydrochlorothiazide therapy]. ( de Miguel Díez, J; García Satue, JL; Jara Chinarro, B; Juretschke Moragues, MA; Serrano Iglesias, JA, 2003) |
| "Amlodipine treatment was associated with a slightly higher incidence of side effects compared with placebo, but most of this difference was the result of edema, which was usually well tolerated." | 2.66 | The safety of amlodipine. ( Osterloh, I, 1989) |
| "We report a case of pulmonary edema induced by a common diuretic, hydrochlorothiazide." | 1.32 | [Acute non-cardiogenic pulmonary edema secondary to hydrochlorothiazide therapy]. ( de Miguel Díez, J; García Satue, JL; Jara Chinarro, B; Juretschke Moragues, MA; Serrano Iglesias, JA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jara Chinarro, B | 1 |
| de Miguel Díez, J | 1 |
| García Satue, JL | 1 |
| Juretschke Moragues, MA | 1 |
| Serrano Iglesias, JA | 1 |
| Osterloh, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in Newly Diagnosed and Uncontrolled Hypertensive Patients[NCT03738761] | Phase 4 | 471 participants (Actual) | Interventional | 2018-02-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydrochlorothiazide and Flushing
| Article | Year |
|---|---|
The safety of amlodipine.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; D | 1989 |
1 other study available for hydrochlorothiazide and Flushing
| Article | Year |
|---|---|
[Acute non-cardiogenic pulmonary edema secondary to hydrochlorothiazide therapy].
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diarrhea; Diuretic | 2003 |